1103 related articles for article (PubMed ID: 17487119)
1. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
2. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
3. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
[TBL] [Abstract][Full Text] [Related]
5. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
6. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
8. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
11. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
13. [A case of renal pelvic squamous cell carcinoma accompanied with humoral hypercalcemia of malignancy (HHM)].
Furukawa M; Tohbu S; Matsuo T; Hayashida Y; Takehara K; Tsuda S; Maeda K; Iwasaki S; Saito Y; Iwasaki K; Nakashima M
Hinyokika Kiyo; 2005 Apr; 51(4):265-8. PubMed ID: 15912787
[TBL] [Abstract][Full Text] [Related]
14. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
[TBL] [Abstract][Full Text] [Related]
15. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
16. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
Body JJ; Dumon JC; Thirion M; Cleeren A
J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
[TBL] [Abstract][Full Text] [Related]
17. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels.
Starr FL; DeCresce R; Prinz RA
Surgery; 2000 Dec; 128(6):930-5;discussion 935-6. PubMed ID: 11114626
[TBL] [Abstract][Full Text] [Related]
18. PTH-independent hypercalcaemia and non-melanoma skin cancer.
Nicolae I; Schipor S
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):449-52. PubMed ID: 19778357
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
20. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]